The company will use the investment to fuel the expansion of its FDA-cleared, AI-enabled surgical navigation platform, Paradigm.
Proprio raises $43M to commercialize surgical navigation platform
The company will use the investment to fuel the expansion of its FDA-cleared, AI-enabled surgical navigation platform, Paradigm.
